Picture of VivoSim Labs logo

VIVS — VivoSim Labs News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Organovo Collaborates With Mcri And Leiden University Medical Center To Develop Stem Cell-Based Bioprinted Tissue Treatments For Kidney Disease

May 30 (Reuters) - Organovo Holdings Inc  ONVO.O :
    * ORGANOVO COLLABORATES WITH MCRI AND LEIDEN UNIVERSITY
MEDICAL
CENTER TO DEVELOP STEM CELL-BASED BIOPRINTED TISSUE TREATMENTS
FOR KIDNEY DISEASE
    * ORGANOVO HOLDINGS - PROJECT WILL EXPAND USE OF 3D
BIOPRINTED
STEM CELL-BASED THERAPEUTIC TISSUES TO APPLICATIONS AIMED AT
END-STAGE RENAL DISEASE

Source text for Eikon:  ID:nGNX9cC4NQ 
Further company coverage:  ONVO.O 

 ((Briefs@thomsonreuters.com;))

Recent news on VivoSim Labs

See all news